Metallothionein, Neurotrophins and Selegiline in Providing Neuroprotection in Parkinson's Disease

Article type: Research Article

Authors: Ebadi, M. | Ramana Kumari, M.V. | Hiramatsu, M. | Hao, R. | Pfeiffer, R.F. | Rojas, P.

Affiliations: Department of Pharmacology, University of Nebraska College of Medicine, Omaha, NE, USA | Department of Neurology, University of Tennessee College of Medicine, Memphis, TN, USA | Institute of Life Support Technology, Yamagata Technopolis Foundation, Yamagata, Japan

Note: [] Corresponding author: M. Ebadi, Ph D., Department of Pharmacology, University of Nebraska College of Medicine, 600 South 42nd Street, Omaha, NE 68198-6260, USA. Tel.(lab.): +1 402 559 8245; Tel.(office): +1 402 559 5140; Fax: +1 402 559 7495; E-mail: [email protected]

Abstract: The finding that 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) elicits parkinsonism in human beings suggests that endogenous or xenobiotic neurotoxic compounds may be involved in the etiology of Parkinson's disease (PD). We have shown that cerebrospinal fluid (CSF) of newly diagnosed and drug untreated patients with PD contains a low molecular weight substance(s) which inhibits the growth and function of dopaminergic neurons in culture. In addition, selegiline in a dosage below the level that inhibits monoamine oxidase B (MAO-B), protects dopaminergic neurons in culture against toxic factor(s) present in the CSF of patients with PD, and the said effect is mediated via elaboration of brain-derived neurotrophic factor (BDNF). In view of the fact that 6-hydroxydopamine (6-OHDA) or MPTP causes parkinsonism by generating free radicals, and inducers of metallothionein (MT) isoforms avert the said neurotoxicity, we intended to learn whether MT isoforms were capable of scavenging free radicals. By employing electron spin resonance spectroscopy (ESR), we examined for the first time the free radical scavenging effects of MT-I and MT-II isoforms on four types of free radicals. Solutions of 0.15 mM of MT-I and 0.3 mM of MT-II scavenged the 1,1-diphenyl-2-picrylhydrazyl radicals completely. Furthermore, they were able to scavenge hydroxyl radicals generated in a Fenton reaction. Moreover, MT-I scavenged almost 90% of the superoxide generated by the hypoxanthine and xanthine oxidase system, while MT-II could only scavenge 40%. By using 2,2,6,6-tetramethyl-4-piperidone as a "spin-trap" for the reactive oxygen species (containing singlet oxygen, superoxide and hydroxyl radicals) generated by photosensitized oxidation of riboflavin, and measuring the relative signal intensities of the resulting stable nitroxide adduct, 2,2,6,6-tetramethyl-4-piperidone-1-oxyl, we observed that MT-II could scavenge 92%, while MT-I could completely scavenge all the reactive species generated. The results of this investigation are interpreted to suggest that selegiline by preventing the generation of free radicals, MT isoforms by scavenging free radicals, and neurotrophins by rescuing dopaminergic neurons are capable of attenuating oxidative stress and of providing neuro-protection in PD.

Keywords: selegiline, 6-hydroxydopamine, dopamine, nerve growth factor, brain-derived neurotrophic factor, oxygen free radicals

Journal: Restorative Neurology and Neuroscience, vol. 12, no. 2-3, pp. 103-111, 1998